| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0168-8278(05)80558-6 |
| P698 | PubMed publication ID | 8151107 |
| P50 | author | Claudio Tiribelli | Q41817157 |
| Massimo Zuin | Q46429802 | ||
| P2093 | author name string | M Podda | |
| S Bellentani | |||
| F Callea | |||
| A Crosignani | |||
| R Merlini | |||
| M Sodde | |||
| M Marazzi | |||
| P M Batezzati | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration | Q28335885 | ||
| Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 | ||
| Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study | Q41916901 | ||
| Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial | Q43723518 | ||
| Prognosis in primary biliary cirrhosis: model for decision making | Q46316848 | ||
| Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Q50878460 | ||
| Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group. | Q59353134 | ||
| Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis | Q68084449 | ||
| Ursodeoxycholic acid for primary sclerosing cholangitis | Q68095108 | ||
| Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man | Q68583675 | ||
| Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids | Q68693124 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion | Q69443241 | ||
| Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? | Q69896715 | ||
| Altered bile acid metabolism in primary biliary cirrhosis | Q70824773 | ||
| Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties--studies on isolated hepatocytes and lipid membrane vesicles | Q71428832 | ||
| P433 | issue | 3 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| hepatitis A | Q157661 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 459-464 | |
| P577 | publication date | 1993-11-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial | |
| P478 | volume | 19 |
| Q35375487 | Anti-inflammatory drugs reduce the risk of hepatocellular carcinoma development |
| Q33370676 | Complementary treatments of chronic viral hepatitis C |
| Q42977234 | Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C. |
| Q44405390 | Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study |
| Q38849427 | Evidence-based clinical practice guidelines for liver cirrhosis 2015. |
| Q34147508 | Hepatocyte Death: A Clear and Present Danger |
| Q43000126 | Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patients |
| Q73562590 | Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis |
| Q41164158 | Pathophysiology and treatment of hepatitis C. |
| Q26853520 | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy |
| Q73574823 | The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone |
| Q34408947 | The management of chronic hepatitis C virus infection |
| Q37358534 | Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review. |
| Q34330984 | Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. |
| Q77598543 | Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications |
Search more.